https://www.selleckchem.com/pr....oducts/mitoquinone-m
Background There is limited information about acute phase renal replacement therapy (RRT) for maintenance hemodialysis patients after the onset of cerebrovascular disease. This study aimed to investigate which modality of renal replacement therapy is currently selected in practice. Methods We conducted a mail-based survey in 317 dialysis facilities that were certified by three academic societies that focus on dialysis, neurology, and neurosurgery in Japan. Results We received responses from 103 facilities (32.5%). In cases
Like
Comment
Share
